Changes in Commercial Insurance Claims for Contraceptive Services During the Beginning of the COVID-19 Pandemic—United States, January 2019–September 2020

Details

• Alternative Title:
  Womens Health Issues
• Personal Author:
  Curtis, Kathryn M. ; Kulkarni, Aniket D. ; Nguyen, Antoinette ; Zapata, Lauren B. ; Kortsmit, Katherine ; Smith, Ruben A. ; Whiteman, Maura K.
• Description:
  Objective:
  
  We describe changes in commercial insurance claims for contraceptive services during the beginning of the COVID-19 pandemic.
  
  Methods:
  
  We analyzed commercial insurance claims using IQVIA PharMetrics® Plus data from over 9 million U.S. females aged 15–49 years, enrolled during any month, January 2019–September 2020. We calculated monthly rates of outpatient claims for intrauterine devices (IUDs), implants, and injectable contraception and monthly rates of pharmacy claims for contraceptive pills, patches, and rings. We used Joinpoint regression analysis to identify when statistically significant changes occurred in trends of monthly claims rates for each contraceptive method. We calculated monthly percentages of claims for contraceptive counseling via telehealth.
  
  Results:
  
  Monthly claims rates decreased for IUDs (−50%) and implants (−43%) comparing February 2020 with April 2020 but rebounded by June 2020. Monthly claims rates for injectables decreased (−19%) comparing January 2019 with September 2020, and monthly claims rates for pills, patches, and rings decreased (−22%) comparing July 2019 with September 2020. The percentage of claims for contraceptive counseling occurring via telehealth was low (<1%) in 2019, increased to 34% in April 2020, and decreased to 9–12% in June–September 2020.
  
  Conclusions:
  
  Substantial changes in commercial insurance claims for contraceptive services occurred during the beginning of the COVID-19 pandemic, including transient decreases in IUD and implant claims and increases in telehealth contraceptive counseling claims. Contraceptive claims data can be used by decision makers to identify service gaps and evaluate use of interventions like telehealth to improve contraceptive access, including during public health emergencies.
  
  
• Subjects:
  Contraception Contraceptive Agents, Female COVID-19 Female Humans Insurance Pandemics United States
• Keywords:
  Claims Analysis Contraception
• Source:
  Womens Health Issues. 34(2):186-196
• Pubmed ID:
  38065719
• Pubmed Central ID:
  PMC11283820
• Document Type:
  Journal Article
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Volume:
  34
• Issue:
  2
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:009a52cb28f5c475421b76bf2ecb715b830529d7e2106f95caab3355bc5334f49e2e9a97654d19c3e4f8cd1e54e3245265acdce660ec40d5243408fe3598528e
• Download URL:
  https://stacks.cdc.gov/view/cdc/159448/cdc_159448_DS1.pdf
• File Type:
  [PDF - 1.21 MB ]